These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 38107601)

  • 1. Non-communicable Diseases Week: Best Practices in Addressing the NCDs Burden from Tanzania.
    Njiro BJ; Ngowi JE; Ndumwa HP; Amani D; Munishi C; Mloka D; Balandya E; Rugajo P; Kessy AT; Ubuguyu O; Salum B; Kamuhabwa A; Ramaiya K; Sunguya BF; Mboya EA; Kikula AI; Kitambala E; Kiologwe J; Kengia JT; Kapologwe N
    Ann Glob Health; 2023; 89(1):89. PubMed ID: 38107601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitigating the Rising Burden of Non-Communicable Diseases through Locally Generated Evidence-Lessons from Tanzania.
    Ndumwa HP; Amani DE; Ngowi JE; Njiro BJ; Munishi C; Mboya EA; Mloka D; Kikula AI; Balandya E; Ruggajo P; Kessy AT; Kitambala E; Kapologwe N; Kengia JT; Kiologwe J; Ubuguyu O; Salum B; Kamuhabwa A; Ramaiya K; Sunguya BF
    Ann Glob Health; 2023; 89(1):77. PubMed ID: 38025921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. National Non-Communicable Diseases Conferences- A Platform to Inform Policies and Practices in Tanzania.
    Amani DE; Ndumwa HP; Ngowi JE; Njiro BJ; Munishi C; Mboya EA; Mloka D; Kikula AI; Balandya E; Ruggajo P; Kessy AT; Kitambala E; Kapologwe N; Kengia JT; Kiologwe J; Ubuguyu O; Salum B; Kamuhabwa A; Ramaiya K; Sunguya BF
    Ann Glob Health; 2024; 90(1):18. PubMed ID: 38463453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protocol for establishing an Adaptive Diseases control Expert Programme in Tanzania (ADEPT) for integrating care of communicable and non-communicable diseases using tuberculosis and diabetes as a case study.
    Mpagama SG; Ramaiya K; Lillebæk T; Mmbaga BT; Sumari-de Boer M; Ntinginya NE; Alffenaar JW; Heysell SK; Bygbjerg IC; Christensen DL
    BMJ Open; 2021 Apr; 11(4):e041521. PubMed ID: 33910944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of chronic conditions in resource limited settings: multi stakeholders' perception and experiences with receiving and providing integrated HIV, diabetes and hypertension services in Tanzania.
    Shayo EH; Murdoch J; Kiwale Z; Bachmann M; Bakari M; Mbata D; Masauni S; Kivuyo S; Mfinanga S; Jaffar S; Van Hout MC
    BMC Health Serv Res; 2023 Oct; 23(1):1120. PubMed ID: 37858150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Public health concern and initiatives on the priority action towards non-communicable diseases in Tanzania.
    Mfinangai SG; Kivuyo SL; Ezekiel L; Ngadaya E; Mghamba J; Ramaiya K
    Tanzan J Health Res; 2011 Dec; 13(5 Suppl 1):365-77. PubMed ID: 26591991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Responding to non-communicable diseases in Zambia: a policy analysis.
    Mukanu MM; Zulu JM; Mweemba C; Mutale W
    Health Res Policy Syst; 2017 Apr; 15(1):34. PubMed ID: 28438177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High prevalence of hypertension and of risk factors for non-communicable diseases (NCDs): a population based cross-sectional survey of NCDS and HIV infection in Northwestern Tanzania and Southern Uganda.
    Kavishe B; Biraro S; Baisley K; Vanobberghen F; Kapiga S; Munderi P; Smeeth L; Peck R; Mghamba J; Mutungi G; Ikoona E; Levin J; Bou Monclús MA; Katende D; Kisanga E; Hayes R; Grosskurth H
    BMC Med; 2015 May; 13():126. PubMed ID: 26021319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-communicable diseases among adolescents: current status, determinants, interventions and policies.
    Akseer N; Mehta S; Wigle J; Chera R; Brickman ZJ; Al-Gashm S; Sorichetti B; Vandermorris A; Hipgrave DB; Schwalbe N; Bhutta ZA
    BMC Public Health; 2020 Dec; 20(1):1908. PubMed ID: 33317507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment and prioritization of the WHO "best buys" and other recommended interventions for the prevention and control of non-communicable diseases in Iran.
    Bakhtiari A; Takian A; Majdzadeh R; Haghdoost AA
    BMC Public Health; 2020 Mar; 20(1):333. PubMed ID: 32171267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Policies for type 2 diabetes and non-communicable disease management during the COVID-19 pandemic in Kenya and Tanzania: a desk review and views of decision-makers.
    Mohamed SF; Kisia L; Mashiashi I; Mair F; Wisdom JP; Bunn C; Gray C; Kibe PM; Sanya RE; Karugu CH; Mtenga SM; Binyaruka P; Asiki G
    BMJ Open; 2024 Mar; 14(3):e073261. PubMed ID: 38531573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Designing a comprehensive Non-Communicable Diseases (NCD) programme for hypertension and diabetes at primary health care level: evidence and experience from urban Karnataka, South India.
    Jayanna K; Swaroop N; Kar A; Ramanaik S; Pati MK; Pujar A; Rai P; Chitrapu S; Patil G; Aggarwal P; Saksena S; Madegowda H; Rekha S; Mohan HL
    BMC Public Health; 2019 Apr; 19(1):409. PubMed ID: 30991978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multi-sectoral action in non-communicable disease prevention policy development in five African countries.
    Juma PA; Mapa-Tassou C; Mohamed SF; Matanje Mwagomba BL; Ndinda C; Oluwasanu M; Mbanya JC; Nkhata MJ; Asiki G; Kyobutungi C
    BMC Public Health; 2018 Aug; 18(Suppl 1):953. PubMed ID: 30168391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NCD Countdown 2030: worldwide trends in non-communicable disease mortality and progress towards Sustainable Development Goal target 3.4.
    NCD Countdown 2030 collaborators
    Lancet; 2018 Sep; 392(10152):1072-1088. PubMed ID: 30264707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gender and non-communicable diseases in Mexico: a political mapping and stakeholder analysis.
    Orozco-Núñez E; Ojeda-Arroyo E; Cerecer-Ortiz N; Guerrero-López CM; Ramírez-Pérez BM; Heredia-Pi I; Allen-Leigh B; Feeny E; Serván-Mori E
    Health Res Policy Syst; 2024 Apr; 22(1):46. PubMed ID: 38605301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Burden of non-communicable diseases from infectious causes in 2017: a modelling study.
    Coates MM; Kintu A; Gupta N; Wroe EB; Adler AJ; Kwan GF; Park PH; Rajbhandari R; Byrne AL; Casey DC; Bukhman G
    Lancet Glob Health; 2020 Dec; 8(12):e1489-e1498. PubMed ID: 33098769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Burden of cumulative risk factors associated with non-communicable diseases among adults in Uganda: evidence from a national baseline survey.
    Wesonga R; Guwatudde D; Bahendeka SK; Mutungi G; Nabugoomu F; Muwonge J
    Int J Equity Health; 2016 Dec; 15(1):195. PubMed ID: 27905949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrated screening and treatment services for HIV, hypertension and diabetes in Kenya: assessing the epidemiological impact and cost-effectiveness from a national and regional perspective.
    Kasaie P; Weir B; Schnure M; Dun C; Pennington J; Teng Y; Wamai R; Mutai K; Dowdy D; Beyrer C
    J Int AIDS Soc; 2020 Jun; 23 Suppl 1(Suppl 1):e25499. PubMed ID: 32562353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Knowledge of non-communicable diseases and access to healthcare services among adults before and during COVID-19 pandemic in rural Tanzania.
    Sirili N; Kilonzi M; Kiwango G; Lengai E; Nandala R; Mwakawanga DL; Philipo EG; Thobias JM; Frumence G
    Front Public Health; 2024; 12():1342885. PubMed ID: 38605870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stakeholder perceptions on scaling-up community-led interventions for prevention and control of non-communicable diseases in Bangladesh: a qualitative study.
    Akter K; Kuddus A; Jeny T; Nahar T; Shaha S; Ahmed N; King C; Pires M; Haghparast-Bidgoli H; Azad K; Fottrell E; Morrison J
    BMC Public Health; 2023 Apr; 23(1):719. PubMed ID: 37081438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.